Having trouble accessing articles? Reset your cache.

FDA refuses to file Ceplene NDA

EpiCept Corp. (NASDAQ:EPCT; SSE:EPCT) fell $0.42 (38%) to $0.68 on Monday after FDA refused to file an NDA

Read the full 188 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE